GlassScriptPhysician profile
David H Kim
NPI 1366485716
$12,114.59
in general payments reported to CMS, 2019-2025
24 companies · $965 in 2025
The $965 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $260 · 2021: $2,724 · 2022: $668 · 2023: $4,524 · 2024: $1,876 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,832 · Travel and Lodging: $2,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,831.98 |
| Travel and Lodging | $2,533.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,736.33 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $2,105.17 | 2021-2024 | Endurant Iis |
| Abbott Laboratories | $1,862.56 | 2019-2023 | Supera, Xact, Jeti |
| Inari Medical, INC. | $1,249.23 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $833.08 | 2019-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Endologix LLC | $811.31 | 2019-2023 | Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $523.37 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Embold Fibered |
| Penumbra, INC. | $382.18 | 2021-2024 | Penumbra System, Indigo System |
| Janssen Pharmaceuticals, INC | $325.61 | 2019-2022 | |
| Lemaitre Vascular, INC. | $282.32 | 2025 | Artegraft Vascular Graft |
| Stryker Corporation | $211.98 | 2025 | Flowtriever |
| Bard Peripheral Vascular, INC. | $172.41 | 2025 | Rotarexs 6 F X 135 Cm |
| Cardiovascular Systems INC. | $139.50 | 2019 | |
| Philips North America LLC | $100.40 | 2021-2023 | |
| Bolton Medical INC | $90.41 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $76.69 | 2019 | |
| Kedrion Biopharma, INC. | $54.62 | 2024-2025 | Gammaked, Kedrab, Albuked |
| Smith+Nephew, INC. | $44.18 | 2024 | Collagenase Santyl |
| Ethicon US, LLC | $24.36 | 2019 | |
| Organogenesis INC. | $22.73 | 2023 | Puraply |
| Merck Sharp & Dohme LLC | $17.19 | 2020 | |
| Heron Therapeutics, INC. | $17.17 | 2024 | Zynrelef |
| Argon Medical Devices, INC. | $16.72 | 2025 | Clot Management |
| Abbvie INC. | $15.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.